Creutzfeldt-Jakob Disease

views updated

Creutzfeldt-Jakob Disease

Resources

Creutzfeldt-Jakob disease is a rare encephalopathy, or brain disease, that causes a swift, progressive dementia and neuromuscular changes. It was first described by German psychiatrist Alfons Maria Jakob (1884–1931) in 1921. He gave credit to Hans Gerhard Creutzfeldt (1885–1964), also a German psychiatrist, for describing the syndrome first without realizing he had stumbled onto a repeating set of symptoms that constitute a syndrome. Although it is now known that what Creutzfeldt described was not the same syndrome that Jakob had discovered, the disease retains its compound name.

Creutzfeldt-Jakob disease (CJD) is the more common of two known human spongiform encephalopathies, the other being kuru. Both encephalopathies are thought to be caused by prions, infectious agents made up of gene-lacking proteins.

The early stages of Creutzfeldt-Jakob disease include symptoms similar to those of Alzheimer’s disease. Disturbances in vision and other senses, confusion, and inappropriate behavior patterns are the usual early signs. During the following months, the person with CJD will invariably progress first to dementia and then into a coma. Jerking movements of the arms and legs are common, and convulsions are less common. Muscle spasms and rigidity occur in the late stages of the disease. Usually, the person will die in less than a year after diagnosis, although some will live for as long as two years.

Creutzfeldt-Jakob disease occurs throughout the world, usually equally among men and women at about age 60. Rarely do young people get the disease. Three forms of the disease have been identified, classified by virtue of transmission. About 10% of Creutzfeldt-Jakob patients in the United States have a positive family history of Creutzfeldt-Jakob disease (hereditary form). About 85% have no identifiable risk factors for the disease, and yet have developed Creutzfeldt-Jakob disease (sporadic form). Only 1% are thought to have contracted the disease through exposure to infective materials (acquired form).

There are no laboratory tests to help diagnose Creutzfeldt-Jakob disease. Many tests performed when a patient is suspected of having CreutzfeldtJakob disease are done to rule out some other, potentially treatable disease. A brain scan using magnetic resonance imaging (MRI) will usually show the degeneration of the cerebrum and enlargement of the brain ventricles (fluid-filled openings in the center of the brain) that characterize encephalopathy. A definitive diagnosis can be made only when a specimen (biopsy) of the brain tissue is stained and studied under a microscope. Biopsying the brain, however, is a highly invasive procedure and is rarely done to diagnose Creutzfeldt-Jakob disease, as information gained from the biopsy does not lead to any change in treatment.

Other neurological measurements are less directly correlated to diagnosing the disease. The electroencephalogram (which monitors the pattern of electric brain waves) may show certain repeated signs, but not always. The cerebrospinal fluid (which fills spaces in the brain and surrounds the spinal cord) may have an elevated level of protein when tested; this measurement is currently being investigated to determine whether the presence or elevation of specific proteins is diagnostic of this disease. The changes seen in brain tissue are not found in any organ outside the central nervous system. The etiologic agent that causes the disease can be found in other organs, but evidently it has no effect on their structure or function.

The causative agent of Creutzfeldt-Jakob disease has unique characteristics. The agent can withstand heat, ionizing radiation, and ultraviolet light— immunities that documented viruses do not possess. Most scientists consider the agent to be a unique, nonviral pathogen that does not contain any DNA or RNA, the nucleic acids containing the reproductive code for any organism. Thus, a new theory emerged and gained widespread acceptance and the infectious agent is now though to be an unconventional proteinaceous particle called a “prion,” (proteinaceous infectious agent). Prion proteins are thought to be proteins that are able to exist in two forms: a normal form, performing some unknown but presumably necessary physiological function in the host, and an abnormal, infectious form, which can cause the disease. When a substantial amount of the normal host protein is converted to the abnormal form (by processes which are not understood fully to date) prion disease can ensue.

The primary means of transmitting this disease is unproven. A case has been documented in which a patient who received a transplanted cornea from the eye of a person with Creutzfeldt-Jakob disease also developed the disease. Another person contracted the disease when electrodes previously used on an infected patient were used in an electroencephalogram. Other cases have been linked to the use of contaminated human growth hormone. Even the occurrence of the disease within families is the result of a mysterious mechanism. It is not always seen and may be the result of more than one family member having a genetic predisposition to the disease.

There is no cure for Creutzfeldt-Jakob disease. Symptoms are treated to make the patients more comfortable, but nothing has been found that will interfere with the progress of the disease or kill the causal agent.

Researchers are interested in more clearly understanding the prion infective agent, and defining its characteristics and the methods of transmission. Contaminated feed has been held responsible for a related disease in cattle called bovine spongiform encephalopathy, leading researchers to question whether Creutzfeldt-Jakob disease could also be spread through contaminated food products. Special precautions are required when coming in contact with highly infective tissues in persons with CJD, including the eye, spinal, and brain tissue. Disposable medical equipment is used whenever possible and stringent sterilization methods for surgical instruments are followed.

Beginning in the early 1990s in the United Kingdom, several unusual cases of CJD in younger people were reported by physicians. These cases surfaced in 1994 and 1995, with a disease that differed significantly from classical sporadic CJD and has been termed variant CJD (vCJD). The patients were all under the age of 42, with an average age of 28, as opposed to the typical age of 63 for classical CJD. The average course of the duration of vCJD was 13 months, in contrast to the average 4-6 month duration for classical CJD. The electroencephalographic (EEG) electrical activity in the brain for vCJD was different from classical CJD. While the brain pathology of the vCJD cases was identifiable as CJD, the pattern differed because of the presence of large aggregates of prion protein plaques. Scientists ascertained a likely connection between this new form of CJD and bovine

KEY TERMS

Cerebrum— The upper, main part of the human brain, it is made up of the two hemispheres, and is the most recent brain structure to have evolved. It is involved in higher cognitive functions such as reasoning, language, and planning.

Encephalopathy— Any abnormality in the structure or function of the brain.

Etiologic agent— The cause of a disease. An etio-logic agent could be a bacterium, a virus, a parasite, or some other factor.

spongiform encephalopathy (BSE), a prion disease in cattle, which reached epidemic proportions in the 1980s in the United Kingdom. There have now been over 150 cases of vCJD, most of which have occurred in the United Kingdom, and the numbers are still rising. A few cases of vCJD in humans have been found in France, Canada, Ireland, Italy, Hong Kong, and one case was observed in the United States in a girl who grew up in England. Because the incubation period between exposure to the agent and the onset of symptoms may be as long as 40 years, it is uncertain whether these vCJD cases may signal the beginning of a large epidemic or whether the incidence of vCJD will remain relatively low. Also, three instances of vCJD have been found in recipients of blood transfusions (not including plasma products) where the donor was unknowingly infected with the CJD agent. With this evidence that the disease can be passed from human to human via blood transfusion, in 2003, health authorities in the United Kingdom required all people who have previously received blood transfusions to refrain from donating blood in the future.

Creutzfeldt-Jakob disease remains a medical mystery, since scientists are not yet certain about its means of transmission, its cure, or its prevention. Much work is being done to collect brain and other tissues, along with body fluid samples from persons who die of vCJD, in order to advance research into the disease.

See also Neuroscience.

Resources

BOOKS

Klitzman, Robert. The Trembling Mountain: A Personal Account of Kuru, Cannibals, and Mad Cow Disease. London: Perseus, 2001.

Margulies, Phillip. Creutzfeldt-Jacob Disease (Epidemics). New York: Rosen Publishers, 2003.

Prusiner, Stanley B. Prion Biology and Diseases, . 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 2003.

OTHER

Creutzfeldt-Jakob Disease Foundation, Inc. P.O. Box 5312 Akron, Ohio 44334. <www.cjdfoundation.org> (January, 15, 2003).

Larry Blaser

More From encyclopedia.com